Pfizer, Anti-DEI Group End Suit Over Diversity Fellowship (1)

Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year Breakthrough Fellowship Program designed to build a diverse pipeline of scientific talent.

Attorneys for the pharmaceutical giant and plaintiff conservative advocacy group Do No Harm made the announcement in a joint stipulation of dismissal filed with the US District Court for the Southern District of New York on Friday.

The agreement comes weeks after the US Court of Appeals for the Second Circuit revived the case and remanded it for further proceedings, finding that the district court applied the wrong standard in assessing ...